Why We Do It
We are invested in making a meaningful difference in the lives of patients and their families around the globe.
We do this by advancing innovative solutions for clinical practice that are sustainable, cost-effective and accessible.
“We wouldn’t be alive today without Fogarty Innovation.”
– Company-In-Residence CEO
At our core…
We behave with integrity first and foremost, knowing we affect the lives of patients and their loved ones.
We put team before self, valuing mutual trust and respect for each other, and sharing a foundational belief that strong teams enhance performance.
We believe in equality and seek diversity to keep growing as a team — not only in race and gender, but also in expression.
We value continuous learning, both as teachers and perpetual students.
We believe the process of innovation is a discipline that can be taught and honed.
We trust in the power of an audacious vision because it taps into a basic human desire: belonging to and believing in something bigger than ourselves.
We have a sense of wonder and a spirit of adventure as we push boundaries to create positive impact on the global medical ecosystem.
We stay humble for all that remains to be done in shaping the future of human health.
We believe these things because we have seen the power of their impact
COVID-19 might have temporarily closed dentist offices, but that hasn’t stopped iDentical from raising a healthy amount of cash for its innovative alternative to traditional dental implants. Fogarty Institute company-in-residence iDentical has developed drill-free,...
Most successful professionals will agree that if there is a “secret to success,” it’s having a mentor. And that holds true for the medtech profession as well, judging by the results of our Diversity by Doing (DxD) HealthTech survey. As noted in our recent report, both...
A $2 Million Grant From the National Cancer Institute A Highlight of a Noteworthy Year for EnSpectra Health
It has been an action-packed 12 months for EnSpectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology. While 2019 brought a number of notable developments, most recently EnSpectra received a $2 million grant that...